GGrantIndex
Sort

51,593 grants matching hepatitis

Molecular Basis of CD1D1 and Natural T Cell Function

$385,275
Sebastian Joyce · Vanderbilt University · R01 · FY2011 · AI

Novel Pharmacological Treatment for Preeclampsia

$385,272
Mohammad Nasir Uddin · Artemis Biotechnologies Llc · R43 · FY2023 · HD

Mechanistic insights into the crosstalk between iron metabolism and diabetes

$385,262
Peijian He · Emory University · R01 · FY2022 · DK

Hepatic Stellate Cell Activation induced by HCV

$385,237
Columbia University Health Sciences · R01 · FY2004 · AA

Ketogenic Oscillations and Neurometabolic Healthspan

$385,204
Peter A Crawford · University Of Minnesota · R01 · FY2021 · AG

Immunity and Virus Disease

$385,198
Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · R37 · FY2007 · AI

Correction of Hemophilia by Embryonic Stem Cell Transplantation

$385,198
Jeffrey Haskell Fair · Cedars-Sinai Medical Center · R01 · FY2008 · HL

Core A-- Animal and Surgical

$385,181
Jeanne M Wallace · Wake Forest University Health Sciences · P01 · FY2007 · HL

MAT1A NULL MOUSE: MODEL FOR ALCOHOLIC TISSUE INJURY

$385,172
University Of Southern California · R01 · FY2003 · AA

Inhibition of the Interferon Response by West Nile Virus

$385,165
Christoph Seeger · Research Inst Of Fox Chase Can Ctr · R01 · FY2009 · AI

Epidemiology of Celiac Disease: A Population Based Study

$385,159
Joseph A Murray · Mayo Clinic Rochester · R01 · FY2009 · DK

Hepatic Drug Transporters in Drug Disposition

$385,153
Vanderbilt University · R01 · FY2003 · GM

Homocysteine, ER Stress and Alcoholic Liver Injury.

$385,146
Neil Kaplowitz · University Of Southern California · R01 · FY2010 · AA

The Mutant Mouse Resource and Research Center at the University of Missouri - Applied Research Section 1

$385,120
Aaron Ericsson · University Of Missouri-Columbia · U42 · FY2020 · OD

The Mutant Mouse Resource and Research Center at the University of Missouri

$385,120
Craig L Franklin · University Of Missouri-Columbia · U42 · FY2020 · OD

VEGF Regulation of Hepatic Erythropoietin Synthesis

$385,099
Stanford University · R01 · FY2005 · HL

BEASTS-Novel Biomimetic Liver Platform for Enabling ALD Researchers

$385,072
Srivatsan S Kidambi · Keshava Biosciences Llc · R43 · FY2023 · AA

Molecular Pharmacology of Insulin Resistance in Burns

$385,044
Jeevendra Martyn · Massachusetts General Hospital · R01 · FY2011 · GM

Role of FGF21 as a Hormonal Mediator of PPARalpha Actions, Project 4 of 10

$385,043
David J Mangelsdorf · Ut Southwestern Medical Center · RL1 · FY2008 · GM

Taskforce for Obesity Research at Southwestern (TORS)

$385,043
Jay D Horton · Ut Southwestern Medical Center · UL1 · FY2010 · DE

Role of FGF21 as a Hormonal Mediator of PPARalpha Actions, Project 4 of 10

$385,043
David J Mangelsdorf · Ut Southwestern Medical Center · RL1 · FY2009 · GM

Taskforce for Obesity Research at Southwestern (TORS)

$385,043
Jay D Horton · Ut Southwestern Medical Center · UL1 · FY2009 · DE

Taskforce for Obesity Research at Southwestern (TORS)

$385,043
Jay D Horton · Ut Southwestern Medical Center · UL1 · FY2008 · DE

Molecular determinants of hepatitis C virus assembly

$385,036
Brett D. Lindenbach · Yale University · R01 · FY2013 · AI

Role of gammaHV68 M1 antigen in Vbeta4+ T cell expansion and fibrosis

$385,026
Samuel H Speck · Emory University · R01 · FY2011 · AI